US Stock MarketDetailed Quotes
TIL Instil Bio
- 10.6000
- +0.2000+1.92%
Close Apr 26 16:00 ET
- 10.5100
- -0.0900-0.85%
Post 16:06 ET
68.94MMarket Cap-441P/E (TTM)
10.7450High10.4500Low6.56KVolume10.4500Open10.4000Pre Close69.33KTurnover0.22%Turnover RatioLossP/E (Static)6.50MShares14.000052wk High0.31P/B32.39MFloat Cap6.060052wk Low--Dividend TTM3.06MShs Float589.8000Historical High--Div YieldTTM2.84%Amplitude6.0600Historical Low10.5650Avg Price1Lot Size
About Instil Bio Company
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Company Profile
SymbolTIL
Company NameInstil Bio
Listing DateMar 19, 2021
Issue Price20.00
Founded2018
CEOMr. Bronson Crouch
MarketNASDAQ
Employees49
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3963 Maple Avenue,Suite 350
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75225
Phone1-972-499-3350
Websitehttp://www.instilbio.com
Company Executives
- Name
- Position
- Salary
- Bronson Crouch
- Chief Executive Officer and Chairman of the Board
- 4.89M
- Dr. Sandeep Laumas, M.D.
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 1.81M
- George Matcham, PhD
- Independent Director
- 191.38K
- Dr. Neil Gibson,PhD
- Lead Independent Director
- 216.88K
- Dr. Gwendolyn Binder-Scholl, M.D.,PhD
- Independent Director
- 192.38K
- R. Kent McGaughy, Jr
- Independent Director
- 199.38K
- Jack Bech Nielsen
- Independent Director
- 191.88K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg